Biomit Inc. Continues Expansion in Europe

Affiliate office opened in Germany; representation in Benelux and Great Britain

09.01.2002

Basel Switzerland January 9 2 2 Biomit Inc a strategic e clinical research partner for the biopharmaceutical industry continues to establish offices throughout Europe as it expands its integrated worldwide representation Today marks the official opening of its office in Heidelberg which will coordinate on line electronic clinical research trials in Germany As well Biomit is now represented in Benelux and Great Britain to expand its reach in providing innovative internet based clinical research trial management Heading the Heidelberg office is Peter X Kunz PhD who brings to Biomit extensive experience in clinical research including eleven years as Clinical Research Scientist managing product development and international clinical trials His fields of expertise include medical imaging in radiology cardiology and urology as well as ultrasound contrast media Strategically located within the Heidelberg Technologypark with more than 3 biotech and pharma companies nearby this affiliate office will coordinate marketing activities and clinical trials in Germany In addition Dieter Wetzel MD PhD will represent Biomit in Benelux and Great Britain assuming responsibilities for business development and clinical trial coordination there With long term experience in scientific information and drug development including scientific drug information for and communication with health care professionals and patients drug in and out licensing analysis of drug markets and competitors as well as marketing strategies and communication concepts Dr Wetzel is expert in the management of clinical trials and drug registration Focus therapeutic areas include neurology and oncology The opening of our office in Germany together with representation in Benelux and Great Britain marks an important second milestone in achieving our long term goal of setting up operations throughout Europe said Urs Gasser co founder and CSO of Biomit who has recently become a Member of the Board of the Swiss Association of Pharmaceutical Professionals SwAPP Dieter Wetzel and Peter Kunz are tremendous additions to our growing expert team of clinical research professionals

Weitere News aus dem Ressort Wirtschaft & Finanzen

Meistgelesene News

Weitere News von unseren anderen Portalen

Kampf gegen Krebs: Neueste Entwicklungen und Fortschritte